Skip to main content
. Author manuscript; available in PMC: 2022 Sep 14.
Published in final edited form as: Gastroenterology. 2020 May;158(6):1789–1810.e15. doi: 10.1053/j.gastro.2020.02.039

Table 1.

Summary of Findings for PICO Question 1a

PPI compared to placebo for EoE
Outcomes and follow-up No. of participants (studies)2648 Certainty of the evidence (GRADE) Relative effect, RR (95% CI) Anticipated absolute effects
Risk with placebo Risk difference with PPI
Not achieving histologic remission (<15 eos/hpf); follow-up: mean 8 wk 1051 (23 observational studies)b ⊕◯◯◯ VERY LOWc,d 0.66 (0.61–0.72)e 867 per 1000 295 fewer per 1000 (338 fewer to 243 fewer)
a

The risk in the intervention group (and its 95% CI) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).

b

Included 2 RCTs of PPI vs topical steroids.

c

I2 = 81%; very inconsistent results in absolute terms.

d

Patients are different than for other interventions where PPI responders were excluded.

e

Used historical control cohort of placebo arm of topical steroid studies.